Traders Purchase High Volume of CME Group Call Options (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) was the target of some unusual options trading activity on Wednesday. Stock traders bought 8,099 call options on the stock. This is an increase of 129% compared to the average volume of 3,537 call options.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group beat Q2 expectations, reporting adjusted EPS of $2.99 versus estimates around $2.91-$2.94 and revenue of about $1.71 billion, slightly above forecasts. CME GROUP ($CME) Releases Q2 2026 Earnings
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, reinforcing bullish sentiment. CME Group jumps after Q2 earnings beat and strong trading activity
• Positive Sentiment: Trading activity remained robust, with second-quarter average daily volume of 29.8 million contracts and record market data revenue of $238 million, suggesting strong demand for hedging and market access. CME Group jumps after Q2 earnings beat and strong trading activity
• Neutral Sentiment: Unusually heavy options activity was also reported, with investors buying 8,099 call options, about 129% above normal, which signals increased speculation and interest in further upside. CME stock is up 7% today. Here’s what we see in our data.
• Neutral Sentiment: Analysts continue to view CME favorably overall, with recent price targets still clustering well above the current share price, though a few firms have trimmed targets recently. $CME stock is up 7% today. Here’s what we see in our data.

Insiders Place Their Bets

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CME. Asset Dedication LLC raised its position in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares in the last quarter. Whipplewood Advisors LLC boosted its holdings in shares of CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares in the last quarter. FNY Investment Advisers LLC bought a new position in shares of CME Group during the 4th quarter valued at about $27,000. Elkhorn Partners Limited Partnership purchased a new position in shares of CME Group during the 4th quarter valued at about $27,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of CME Group during the 4th quarter valued at about $28,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of analyst reports. Keefe, Bruyette & Woods upgraded CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a research note on Thursday, June 18th. Erste Group Bank downgraded CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and lifted their target price for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Raymond James Financial reaffirmed an “outperform” rating and set a $320.00 target price on shares of CME Group in a report on Thursday, July 2nd. Finally, Jefferies Financial Group lowered their target price on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. Twelve equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $292.12.

CME Group Price Performance

Shares of CME stock traded up $14.17 during trading on Wednesday, hitting $251.55. The company had a trading volume of 1,633,443 shares, compared to its average volume of 2,759,275. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock’s 50-day moving average is $256.83 and its two-hundred day moving average is $281.68. The stock has a market capitalization of $91.15 billion, a price-to-earnings ratio of 21.49, a price-to-earnings-growth ratio of 3.05 and a beta of 0.25. CME Group has a 52 week low of $218.31 and a 52 week high of $329.16.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the firm posted $2.96 earnings per share. CME Group’s quarterly revenue was up .8% on a year-over-year basis. As a group, analysts predict that CME Group will post 12.18 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were given a dividend of $1.30 per share. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.1%. CME Group’s dividend payout ratio (DPR) is 44.37%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.